Oligomerix, Inc Company Profile, Contacts & Intelligence

Oligomerix, Inc Overview

Oligomerix is an emerging biotechnology company focused on developing disease-modifying therapeutics for neurodegenerative diseases characterized by aberrant tau protein ranging from rare tauopathies such as progressive supranuclear palsy and frontotemporal dementia to Alzheimer’s disease. With a focus on oral, small molecule, tau self-association inhibitors, Oligomerix seeks to develop therapies for Alzheimer’s disease and other dementias that are easy to administer and cost effective, and which are expected to significantly add to newly emerging high-cost therapeutic options such as the monoclonal antibody targeted against beta-amyloid that was recently approved by the U.S. FDA. Oligomerix is headquartered at the Westchester Park Center in White Plains, New York and has lab facilities at the Ullmann Research Center for Health Sciences within the Albert Einstein College of Medicine.

Headquarters

White Plains, New York, United States

Website

oligomerix.com

Industry

Biotechnology Research

Founded

2006

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Phone Number

Available in AeroLeads

Company Email

Available in AeroLeads

Oligomerix, Inc Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Oligomerix, Inc People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Oligomerix, Inc Workforce Composition

Seniority breakdown across 4 visible profiles.

Compare Similar Companies to Oligomerix, Inc

Explore companies in related markets and compare their industry and employee estimates.